(Q45858971)

17 December 2017

title

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases (English)

1 reference

17 December 2017

1 reference

Berezné A

1

1 reference

17 December 2017

Stieltjes N

2

1 reference

17 December 2017

Le-Guern V

3

1 reference

17 December 2017

Teixeira L

4

1 reference

17 December 2017

Billy C

5

1 reference

17 December 2017

Roussel-Robert V

6

1 reference

17 December 2017

Flaujac C

7

1 reference

17 December 2017

Horellou MH

8

1 reference

17 December 2017

Guillevin L

9

1 reference

17 December 2017

Mouthon L

10

1 reference

17 December 2017

language of work or name

1 reference

1 June 2006

1 reference

17 December 2017

published in

Transfusion Medicine

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

209-212

1 reference

17 December 2017

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

1 reference

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Acquired high-titer factor VIII inhibitor: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Treatment of childhood autoimmune haemolytic anaemia with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Rituximab in the treatment of acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2006.00669.X

10.1111/J.1365-3148.2006.00669.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017